Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
European Journal of Clinical Pharmacology
|
January 1, 1989
The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects
A Van Peer, R Woestenborghs, J Heykants, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
June 1, 1982
Pharmacokinetics of the immunomodulatory 1,2-O-isopropylidene-3-O-3'-(N',N'-dimethyl-amino-n-propyl)-D-glucofuranose hydrochloride in normal human volunteers
E R Garrett, A Van Peer, P Altmayer, et al.
British Journal of Anaesthesia
|
September 1, 1988
Pharmacokinetics of droperidol in surgical patients under different conditions of anaesthesia
K A Lehmann, A Van Peer, M Ikonomakis, et al.
British Journal of Clinical Practice. Supplement
|
September 1, 1990
Pharmacokinetics of oral antifungals and their clinical implications
J Heykants, A Van Peer, K Lavrijsen, et al.
Biomedical Mass Spectrometry
|
January 1, 1985
The use and limitations of deuterated lorcainide in metabolism and pharmacokinetic studies
C F Gelijkens, A Van Peer, H Lenoir, et al.
Journal of Clinical Pharmacology
|
December 1, 1993
Pharmacokinetics of orally administered levocabastine in patients with renal insufficiency
J Zazgornik, M L Huang, A Van Peer, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
September 1, 1989
Comparison of intravenous and intranasal sufentanil absorption and sedation
J H Helmers, H Noorduin, A Van Peer, et al.
Clinical Pharmacokinetics
|
October 1, 1995
The pharmacokinetic properties of topical levocabastine. A review
J Heykants, A Van Peer, V Van de Velde, et al.
Journal of Clinical Pharmacology
|
November 10, 1998
Fentanyl delivery from an electrotransport system: delivery is a function of total current, not duration of current
S K Gupta, K J Bernstein, H Noorduin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 12, 2001
Role of modelling and simulation in Phase I drug development
L Aarons, M O Karlsson, F Mentré, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
European Journal of Clinical Pharmacology
|
January 1, 1989
The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects
A Van Peer, R Woestenborghs, J Heykants, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
June 1, 1982
Pharmacokinetics of the immunomodulatory 1,2-O-isopropylidene-3-O-3'-(N',N'-dimethyl-amino-n-propyl)-D-glucofuranose hydrochloride in normal human volunteers
E R Garrett, A Van Peer, P Altmayer, et al.
British Journal of Anaesthesia
|
September 1, 1988
Pharmacokinetics of droperidol in surgical patients under different conditions of anaesthesia
K A Lehmann, A Van Peer, M Ikonomakis, et al.
British Journal of Clinical Practice. Supplement
|
September 1, 1990
Pharmacokinetics of oral antifungals and their clinical implications
J Heykants, A Van Peer, K Lavrijsen, et al.
Biomedical Mass Spectrometry
|
January 1, 1985
The use and limitations of deuterated lorcainide in metabolism and pharmacokinetic studies
C F Gelijkens, A Van Peer, H Lenoir, et al.
Journal of Clinical Pharmacology
|
December 1, 1993
Pharmacokinetics of orally administered levocabastine in patients with renal insufficiency
J Zazgornik, M L Huang, A Van Peer, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
September 1, 1989
Comparison of intravenous and intranasal sufentanil absorption and sedation
J H Helmers, H Noorduin, A Van Peer, et al.
Clinical Pharmacokinetics
|
October 1, 1995
The pharmacokinetic properties of topical levocabastine. A review
J Heykants, A Van Peer, V Van de Velde, et al.
Journal of Clinical Pharmacology
|
November 10, 1998
Fentanyl delivery from an electrotransport system: delivery is a function of total current, not duration of current
S K Gupta, K J Bernstein, H Noorduin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 12, 2001
Role of modelling and simulation in Phase I drug development
L Aarons, M O Karlsson, F Mentré, et al.
Page
of 7